Current Australian guidelines regarding testing and treatment for prostate cancer recommend informed decision-making regarding PSA testing for asymptomatic men aged 50–69 (Prostate Cancer Foundation of Australia 2016). The gene discussed is KLK3; the disease is prostate cancer.